On Tuesday, Longitude Health announced the appointment of Vishal Agrawal, M.D., to the post of CEO. He succeeds Brett Moraski ...

Excellergy has emerged with $70 million and an investigative drug class in its portfolio, part of its ambitious mission to ...

The U.S. government has agreed to loan privately-held biotechnology firm Ginkgo Bioworks $1.1 billion for COVID-19 testing and the production of raw materials for therapies that may help address ...

VANCOUVER, British Columbia, Oct. 09, 2025 (GLOBE NEWSWIRE) -- via IBN -- Fifty1 AI Labs, a subsidiary of Fifty1 Labs, Inc. (OTC: FITY) and a ...

The administration hopes to make the TrumpRx website available in early 2026. While President Donald Trump announced on Tuesday that Pfizer, one of the leading pharmaceutical companies, had agreed to ...

Barrick Mining (NYSE: B) announced the resignation of President and CEO Mark Bristow today. After nearly seven years at the helm, the South African-born mining veteran departs without explanation, ...

On the latest episode of The Verge's Decoder podcast, released today, Ford CEO Jim Farley told guest host Joanna Stern that the automaker does not entirely like Apple's current implementation of its ...

Comcast has promoted President Mike Cavanagh to the role of co-CEO alongside Brian Roberts, effective Jan. 1, 2026. In his current role, Cavanagh has managed all aspects of Comcast’s business with ...

British pharmaceutical giant GSK on Monday said longtime chief executive Emma Walmsley will be replaced by its chief commercial officer in January, as the company navigates US tariffs on the sector.

GSK chief executive Emma Walmsley will be replaced by chief commercial officer Luke Miels on January 1 - Copyright GETTY IMAGES NORTH AMERICA/AFP Kayla Bartkowski GSK ...